Navigation Links
Acorn Acquisition Corp Announces Definitive Agreement to Acquire Lumen Medical Inc.
Date:10/4/2007

NEW YORK, Oct. 4 /PRNewswire-FirstCall/ -- Acorn Acquisition Corp. (OTC Bulletin Board: ACAQ), a shell company, today announced that it has reached a definitive agreement to acquire Lumen Medical Inc., the owner of 51% of PulmoScience Inc., a development stage biotechnology company that is developing a non-invasive Molecular Imaging technique for the diagnosis of Pulmonary Embolism, Pulmonary Hypertension and Lung Inflammatory diseases under the trade name PulmoBind. Under the terms of the agreement, Lumen Medical Inc. will merge with and into Acorn Acquisition Corp. in consideration of the issuance of an aggregate of 51,250,000 shares of Acorn common stock to the shareholders of Lumen.

Lumen is a privately held company that owns 51% of PulmoScience Inc. and has an option to increase its percentage ownership to 61% by the payment of a cash option exercise price of $200,000. Lumen plans to exercise this option before the end of 2007. The remaining equity of PulmoScience is shared between Innovacor (a subsidiary of the Montreal Heart Institute) and Dr. Jocelyn Dupuis (the originator of the PulmoBind Molecular Imaging technology).

PulmoBind uses an intravenously delivered radionuclide tagged molecule which specifically bonds to the inner walls of the circulatory system in the lungs, and by the use of an external Gamma Camera allows an image of the integrity of the blood vessels throughout the lungs to be seen by a diagnostic clinician. PulmoScience is currently two thirds of the way through Regulatory Approval for Phase I Human Trials, and while subsequent results from additional tests might not corroborate the current results, PulmoScience believes that PulmoBind has the potential to dominate the market for the diagnosis of Pulmonary Embolism. In particular, this belief is driven by PulmoScience's expectations of the improved safety and efficacy that PulmoBind will offer when compared to the current incumbent nuclear medicine based technology for th
'/>"/>

SOURCE Acorn Acquisition Corp.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. NimbleGen to discontinue IPO after Roches $272.5 million acquisition
2. Potawatomis complete acquisition of tech firm
3. GE acquisition may boost "early" healthcare strategy
4. Berbee believes acquisition by CDW will make it a national IT player
5. Some great insights into the current Mergers & Acquisitions Market
6. RedPrairie completes MARC acquisition
7. Merge announces sofware updates, upcoming acquisition
8. Brady continues growth through Asian acquisition
9. RedPrairie to gain wider reach with acquisition
10. GE completes $1.2 billion acquisition
11. Pitney Bowes and Firstlogic cancel acquisition plans
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... PrimeSource Building Products, Inc., a leading ... to support their communication needs with the ... conferencing platform GlobalMeet powered by SoundConnect. The solution ... SoundConnect delivers award winning “results driven” business class ... be utilizing GlobalMeet powered by SoundConnect ...
(Date:8/27/2014)... Green & Grow Inc. (GGI) has raised an ... Otter Capital as a significant new partner. Otter Capital’s ... Agriplier™ technology, building on recent compelling field trial results ... meeting, we have been impressed with Otter Capital’s knowledge ... Sobba, President and CEO of GGI. “We look forward ...
(Date:8/27/2014)... 27, 2014   MSC , a healthcare performance ... announced the appointment of Mary Beth Loesch ... years of experience preparing companies for rapid growth and ... Vice President of Corporate Development and Healthcare. In that ... , as well as corporate strategy and marketing. Previously, ...
(Date:8/27/2014)... , Aug. 27, 2014 Research ... "Global Lactic Acid  (Biodegradable Polymer, Food & ... & Forecasts to 2019" report to their ... hydroxyl-carboxylic acid with an asymmetrical carbon atom. The ... biodegradable polymer, food and beverage, personal care product, ...
Breaking Biology Technology:PrimeSource Chooses SoundConnect as Collaboration Provider 2Green & Grow Inc. Secures $6M Series B Funding from Otter Capital 2Green & Grow Inc. Secures $6M Series B Funding from Otter Capital 3MSC names Mary Beth Loesch President and CEO 2Global Lactic Acid (Biodegradable Polymer, Food & Beverage, Personal Care & Pharmaceutical) Market - Trends & Forecasts to 2019 2
... Inc. (the,"Company") (OTC Bulletin Board: TBIO) today announced financial ... financial results are,presented in the tables that follow. ... profit of $0.2 million or $0.00 per share,for the ... loss of $0.4 million or,$0.01 per share for the ...
... Aug. 14 At the Board of Directors,meeting ... dividend of,$.115 per share. The dividend is payable ... August 31, 2007. About Sigma-Aldrich: Sigma-Aldrich is ... biochemical and organic chemical products and kits,are used ...
... - 17 Percent Quarter-to-Quarter Revenue Gain Evidences Start of Turnaround ... for Core Business ... DelSite Signs Additional Agreements, IRVING, Texas, Aug. 14 Carrington,Laboratories, Inc. (Nasdaq: ... to $6.5 million in the year ago,period. The revenue in the quarter just ended, ...
Cached Biology Technology:Transgenomic, Inc. Reports Second Quarter 2007 Results 2Transgenomic, Inc. Reports Second Quarter 2007 Results 3Transgenomic, Inc. Reports Second Quarter 2007 Results 4Transgenomic, Inc. Reports Second Quarter 2007 Results 5Transgenomic, Inc. Reports Second Quarter 2007 Results 6Transgenomic, Inc. Reports Second Quarter 2007 Results 7Transgenomic, Inc. Reports Second Quarter 2007 Results 8Carrington Reports Second Quarter 2007 Results 2Carrington Reports Second Quarter 2007 Results 3Carrington Reports Second Quarter 2007 Results 4Carrington Reports Second Quarter 2007 Results 5Carrington Reports Second Quarter 2007 Results 6Carrington Reports Second Quarter 2007 Results 7
(Date:8/28/2014)... and more action is needed to ensure safeguards are ... Published in PLOS ONE , researchers from Monash ... meta-analysis - combining results from different studies - to ... these areas, to determine whether they actually protect biodiversity. ... said protecting an area from human exploitation made common ...
(Date:8/27/2014)... mastodons, short-faced bears, giant ground sloths, saber-toothed cats ... 13,000 years ago at the end of the Pleistocene ... been debated by scientists who, until recently, could only ... including UC Santa Barbara,s James Kennett, professor emeritus in ... collision with Earth played a major role in the ...
(Date:8/27/2014)... group of fish began exploring land and evolved into tetrapods ... these ancient fish used their fishy bodies and fins in ... remain scientific mysteries. , Researchers at McGill University published ... fish, called Polypterus , to help show what might ... the water. Polypterus is an African fish that ...
Breaking Biology News(10 mins):Protected areas proven to protect biodiversity 2Nanodiamonds are forever 2Nanodiamonds are forever 3Walking fish reveal how our ancestors evolved onto land 2
... NC A leading bat expert with the USDA Forest ... Georgia, Kentucky, North Carolina, South Carolina and Tennessee that she ... that kills bats and appears to be rapidly spreading south ... Ph.D. says WNS has been confirmed in Tennessee, and she ...
... selected as a 2010-2014 Harold Amos Medical Faculty Development Program ... a national program of the Robert Wood Johnson Foundation. ... of North Carolina at Chapel Hill School of Medicine, is ... the award. Harold Amos scholars are selected based on their ...
... in nasal drug delivery systems, is pleased to announce ... its Phase II clinical study investigating the efficacy and ... treatment of migraine. Sumatriptan powder in ... delivery device was highly effective in treating a single ...
Cached Biology News:Deadly fungus threatens 9 bat species in Ga., Ky., N.C., S.C. and Tenn., expert says 2Deadly fungus threatens 9 bat species in Ga., Ky., N.C., S.C. and Tenn., expert says 3OptiNose's novel intranasal sumatriptan product highly effective in treating migraines 2
Experion HighSens chips are the microfluidic chips used to perform high-sensitivity RNA analysis (picogram levels) with the Experion automated electrophoresis system. Each chip has the capacity to ru...
... are preactivated with carbonyl diimidazole chemistry that ... The PS10 array contains the same binding ... with an updated hydrophobic barrier coating. These ... mm diameter spots spatially compatible with one ...
...
...
Biology Products: